HealthyDirect · Growth
Bajaj Finserv Healthcare Fund
Bajaj Finserv Mutual FundEquity Scheme - Sectoral/ Thematic1.7 years
The Scheme seeks to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies.
- NAV
- 12.084
- 15 Sept 2026
- 1Y
- +22.2%
- Trailing CAGR
- AUM
- ₹376.77 Cr
- 31 Aug 2026
- Volatility
- Medium
- 13.4% annualized
NAV
Path not in current snapshots
n/a
Returns
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
- 1Y+22.2%
- 3Yn/a
- 5Yn/a
- 10Yn/a
- SI+12.2%
SIP XIRR
Equal monthly instalments to latest NAV
- 1Y+39.0%
- 3Yn/a
- 5Yn/a
- 10Yn/a
- Since inception
- +12.2%
- Calendar-day CAGR
- Excess 1Y
- +16.0%
- Category median, same plan and option
- 3Y win rate
- n/a
- Windows beating the median
- 3Y percentile
- n/a
- Vs comparable share classes
- Worst rolling 3Y
- n/a
- 0 daily-ending windows
- Median rolling 3Y
- n/a
- Calendar-day CAGR
- Positive rolling 5Y
- n/a
- 0 daily-ending windows
- SIP 3Y XIRR
- n/a
- Simulated monthly SIP
Drawdown
Peak to trough from a running NAV high. Move across the path to read a date.
Drawdown
Path not in current snapshots
n/a
- Average recovery
- 20 days
- 17 recovered episodes
- Longest recovery
- 262 days
- Trough to prior peak
- Current spell
- 3 days
- Days below latest peak
- Time below peak
- +88%
- NAV observations
2 Jan 2025 – 17 Nov 2025
Trough 28 Feb 2025 · recovered in 262 days
-15.7%
17 Nov 2025 – 4 May 2026
Trough 23 Mar 2026 · recovered in 42 days
-10.1%
21 May 2026 – 12 Jun 2026
Trough 1 Jun 2026 · recovered in 11 days
-2.2%
31 Aug 2026 – 8 Sept 2026
Trough 4 Sept 2026 · recovered in 4 days
-2.0%
Dimensions
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
72
Vs category
100
Consistency
63
Risk-adjusted
52
Drawdown
61
Mean
70
Portfolio
31 Aug 2026 · 37 holdings · top 10 are 61.9%.
- Top 5
- 37.8%
- Top 10
- 61.9%
- Largest holding
- 10.5%
- Effective holdings
- 20.6
Divi's Laboratories Ltd
Healthcare
10.5%
Sun Pharmaceutical Industries Ltd
Healthcare
8.2%
Rubicon Research Ltd.
Healthcare
6.8%
Piramal Pharma Ltd
Healthcare
6.7%
Aurobindo Pharma Ltd
Healthcare
6.2%
Decision
Quantitative read of the live evidence. An explanation can only restate what is already here.
As of 11 Sept 2026
Healthy
Engine status
Healthy
Doing its job
Why this status
- No material deterioration, cost shock, or persistent category underperformance in the current evidence set.
Supporting reads
- The fund beat the category median in 63% of rolling 1-year windows.
- Risk-adjusted return sits above the documented risk-free proxy.
Worth investigating
Same-category peers with enough history to inspect beside this fund.
Kotak Business Cycle Fund
Kotak Mahindra Mutual Fund
- 1Y
- +2.5%
- 3Y
- +14.5%
- Vol
- 12.6%
- Max DD
- -18.4%
- Sharpe
- 0.82
- 3Y win
- +97%
- Lower volatility
- Higher win rate vs category
- Lower TER
Caveat: Deeper drawdown · Lower trailing returns
Baroda BNP Paribas Energy Opportunities Fund
Baroda BNP Paribas Mutual Fund
- 1Y
- +0.7%
- 3Y
- n/a
- Vol
- 13.8%
- Max DD
- -9.7%
- Sharpe
- 0.33
- 3Y win
- n/a
- Shallower drawdown
- Higher win rate vs category
Caveat: Higher volatility · Higher TER · Lower trailing returns
ICICI PRUDENTIAL HOUSING OPPORTUNITIES FUND
ICICI Prudential Mutual Fund
- 1Y
- -3.4%
- 3Y
- +9.8%
- Vol
- 12.6%
- Max DD
- -16.7%
- Sharpe
- 0.67
- 3Y win
- +71%
- Lower volatility
- Higher win rate vs category
Caveat: Deeper drawdown · Lower trailing returns
Motilal Oswal Active Momentum Fund
Motilal Oswal Mutual Fund
- 1Y
- +25.5%
- 3Y
- n/a
- Vol
- 17.1%
- Max DD
- -16.6%
- Sharpe
- 1.25
- 3Y win
- n/a
- Higher win rate vs category
- Higher trailing returns
Caveat: Higher volatility · Deeper drawdown · Higher TER
Tata Digital India Fund
Tata Mutual Fund
- 1Y
- -11.9%
- 3Y
- +4.3%
- Vol
- 18.7%
- Max DD
- -33.3%
- Sharpe
- 0.62
- 3Y win
- +67%
- Higher win rate vs category
- Lower TER
Caveat: Higher volatility · Deeper drawdown · Lower trailing returns